A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy
Clinical trial NCT05248334 · UNKNOWN
Trial details
- NCT number
- NCT05248334
- Sponsor
- Tianjin Medical University Eye Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-10
- Primary completion
- 2024-12-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.